102 related articles for article (PubMed ID: 8869954)
1. Molecular methods for the detection of human papillomavirus infection.
Lörincz AT
Obstet Gynecol Clin North Am; 1996 Sep; 23(3):707-30. PubMed ID: 8869954
[TBL] [Abstract][Full Text] [Related]
2. Generation of type-specific probes for the detection of single-copy human papillomavirus by a novel in situ hybridization method.
Huang CC; Qiu JT; Kashima ML; Kurman RJ; Wu TC
Mod Pathol; 1998 Oct; 11(10):971-7. PubMed ID: 9796725
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of human papillomavirus gynecologic infections.
Wick MJ
Clin Lab Med; 2000 Jun; 20(2):271-87, vi. PubMed ID: 10863641
[TBL] [Abstract][Full Text] [Related]
4. High sensitivity of PCR in situ hybridization for the detection of human papillomavirus infection in uterine cervical neoplasias.
Xiao Y; Sato S; Oguchi T; Kudo K; Yokoyama Y; Saito Y
Gynecol Oncol; 2001 Aug; 82(2):350-4. PubMed ID: 11531292
[TBL] [Abstract][Full Text] [Related]
5. Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types.
Castle PE; Schiffman M; Burk RD; Wacholder S; Hildesheim A; Herrero R; Bratti MC; Sherman ME; Lorincz A
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1394-9. PubMed ID: 12433717
[TBL] [Abstract][Full Text] [Related]
6. [Cytopathology and histopathology of human papilloma virus].
Ishi K; Suzuki F; Saito A; Kina K; Koyatsu J; Kubota T
Rinsho Byori; 1998 Mar; 46(3):229-34. PubMed ID: 9564762
[TBL] [Abstract][Full Text] [Related]
7. [Detection of HPV-DNA in the various uterocervical lesion by the in situ polymerase chain reaction].
Ishi K; Kina K; Koyatsu J; Kawashima T; Suzuki F; Saito A; Kubota T; Igari J
Rinsho Byori; 1997 Jan; 45(1):82-6. PubMed ID: 9022348
[TBL] [Abstract][Full Text] [Related]
8. Validation of hybridization assays: correlation of filter in situ, dot blot and PCR with Southern blot.
Schiffman MH
IARC Sci Publ; 1992; (119):169-79. PubMed ID: 1330908
[TBL] [Abstract][Full Text] [Related]
9. Detection and typing of human papillomavirus nucleic acids in biological fluids.
Coutlée F; Mayrand MH; Roger M; Franco EL
Public Health Genomics; 2009; 12(5-6):308-18. PubMed ID: 19684443
[TBL] [Abstract][Full Text] [Related]
10. Detection of human papillomavirus in cervical carcinoma: comparison of peroxidase, Nanogold, and catalyzed reporter deposition (CARD)-Nanogold in situ hybridization.
Cheung AL; Graf AH; Hauser-Kronberger C; Dietze O; Tubbs RR; Hacker GW
Mod Pathol; 1999 Jul; 12(7):689-96. PubMed ID: 10430273
[TBL] [Abstract][Full Text] [Related]
11. Biology and pathological associations of the human papillomaviruses: a review.
Cheah PL; Looi LM
Malays J Pathol; 1998 Jun; 20(1):1-10. PubMed ID: 10879257
[TBL] [Abstract][Full Text] [Related]
12. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.
Wang-Johanning F; Lu DW; Wang Y; Johnson MR; Johanning GL
Cancer; 2002 Apr; 94(8):2199-210. PubMed ID: 12001118
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus infection is not associated with bronchial carcinoma: evaluation by in situ hybridization and the polymerase chain reaction.
Welt A; Hummel M; Niedobitek G; Stein H
J Pathol; 1997 Mar; 181(3):276-80. PubMed ID: 9155712
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of human papillomavirus-consensus primers for HPV detection by the polymerase chain reaction.
Harnish DG; Belland LM; Scheid EE; Rohan TE
Mol Cell Probes; 1999 Feb; 13(1):9-21. PubMed ID: 10024428
[TBL] [Abstract][Full Text] [Related]
15. Ancillary diagnostic tests for detection of human papillomavirus infection.
Sawchuk WS
Dermatol Clin; 1991 Apr; 9(2):277-86. PubMed ID: 1647906
[TBL] [Abstract][Full Text] [Related]
16. [Detection of human papillomavirus in laryngeal carcinoma with digoxigenin labelled probe prepared by polymerase chain reaction].
Zhao S; Ye Q; Lu S
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Mar; 13(1):13-6. PubMed ID: 12759943
[TBL] [Abstract][Full Text] [Related]
17. Detection of high-risk HPV types by the hybrid capture 2 test.
Terry G; Ho L; Londesborough P; Cuzick J; Mielzynska-Lohnas I; Lorincz A
J Med Virol; 2001 Sep; 65(1):155-62. PubMed ID: 11505458
[TBL] [Abstract][Full Text] [Related]
18. Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirus testing.
Sherman ME; Schiffman MH; Lorincz AT; Herrero R; Hutchinson ML; Bratti C; Zahniser D; Morales J; Hildesheim A; Helgesen K; Kelly D; Alfaro M; Mena F; Balmaceda I; Mango L; Greenberg M
Cancer; 1997 Apr; 81(2):89-97. PubMed ID: 9126136
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus cervical infection and associated risk factors in a region of Argentina with a high incidence of cervical carcinoma.
Tonon SA; Picconi MA; Zinovich JB; Liotta DJ; Bos PD; Galuppo JA; Alonio LV; Ferreras JA; Teyssié AR
Infect Dis Obstet Gynecol; 1999; 7(5):237-43. PubMed ID: 10524669
[TBL] [Abstract][Full Text] [Related]
20. [Genotyping of human papillomavirus genotyes in cervical scrapes by line probe assay].
Wang J; Bakkers J; Melchers WJ
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Mar; 13(1):9-12. PubMed ID: 12759942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
